Schnitzler syndrome is a very rare autoinflammatory disease that seems to arise from an IgM monoclonal gammopathy [1] [2] [3] [4]. The pathogenesis still remains incompletely understood, but the clinical presentation has been well-documented in the literature. The cardinal feature of patients suffering from Schnitzler syndrome is a chronic urticarial rash [1] [2] [3]. Urticaria is the presenting manifestation in many individuals and appears years before other notable symptoms and signs of Schnitzler syndrome [3] [4] [5] [6]:

• Fever - A chronic course of fever that possesses an intermittent pattern is seen in 75% of patients [1] [3] [6] [7]. Fever often accompanies the onset of urticaria, while some cases have been described in whom the rash appeared after fever [1] [2].
• Pain - Myalgia, arthralgia, and bone pain are frequent manifestations seen in this syndrome, together with fatigue [1] [3] [4].
• Peripheral neuropathy - From 7%-56% of individuals suffer from peripheral neuropathy according to different studies [1] [3].
• Night sweats, weight loss, hepatomegaly, and splenomegaly are less commonly encountered [1] [2] [7].

Lymphadenopathy is also an important sign, being present in more than 40% of cases [1]. The clinical course of Schnitzler syndrome is often described as several-years long before the diagnosis is made [1] [6]. It is important to mention that similarly to other monoclonal gammopathies, a significant risk exists toward the development of a lymphoproliferative disorder, such as IgM myeloma or marginal B-cell lymphoma [1] [6].

A high index of suspicion is necessary in order to make the diagnosis of Schnitzler syndrome [1]. A thorough history should be obtained first, during which the onset of symptoms (particularly the rash and relapses of fever), their progression, as well as severity must be covered. The physical examination can only confirm the nonspecific findings, which is why laboratory studies are the crucial step in the workup. A complete blood count (CBC) will show anemia and leukocytosis with neutrophilia in a significant number of patients, whereas basic inflammatory parameters will reveal elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) [1] [4]. The detection of an IgM kappa chain raises solid evidence toward Schnitzler syndrome (the presence of IgG is also reported but in very few patients), although their levels may be paradoxically low at the time of diagnosis [1] [2] [4] [6]. Skin biopsy and subsequent histopathological examination is an equally important diagnostic tool, showing a neutrophilic infiltrate in a significant portion of tested patients [7]. Bone marrow biopsy could be recommended in some cases.

The treatment of Schnitzler Syndrome focuses on managing symptoms and improving quality of life. Options include:

• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): To relieve pain and inflammation.
• Corticosteroids: For more severe symptoms, though long-term use is not ideal due to side effects.
• Interleukin-1 (IL-1) Inhibitors: Such as anakinra, which have shown significant efficacy in controlling symptoms by targeting the inflammatory pathway involved in the syndrome.

Schnitzler Syndrome is a chronic condition, and while it is not typically life-threatening, it can lead to significant discomfort and disability. With appropriate treatment, many patients experience substantial relief from symptoms. However, the disease often requires long-term management, and relapses can occur if treatment is discontinued.

The exact cause of Schnitzler Syndrome is not well understood. It is classified as an autoinflammatory disorder, suggesting a genetic or immune system component. The presence of monoclonal gammopathy indicates an abnormal production of certain proteins by the immune system, but the trigger for this process remains unclear.

Schnitzler Syndrome is extremely rare, with only a few hundred cases reported worldwide. It typically affects adults, with a slight male predominance. The rarity of the condition can make diagnosis challenging, often leading to delays in identifying the syndrome.

The pathophysiology of Schnitzler Syndrome involves the overproduction of interleukin-1 (IL-1), a protein that plays a key role in the body's inflammatory response. This overproduction leads to the chronic inflammation seen in the syndrome, manifesting as hives, fever, and other systemic symptoms. The presence of monoclonal gammopathy suggests an underlying immune system dysregulation.

Currently, there are no known preventive measures for Schnitzler Syndrome due to its unclear etiology and rare occurrence. Management focuses on early diagnosis and effective treatment to control symptoms and prevent complications.

Schnitzler Syndrome is a rare autoinflammatory disorder characterized by chronic hives, recurrent fever, and other systemic symptoms. Diagnosis involves clinical evaluation and laboratory tests to rule out other conditions. Treatment primarily includes IL-1 inhibitors, which have proven effective in managing symptoms. While the condition is chronic, appropriate treatment can significantly improve patient outcomes.

If you suspect you have symptoms consistent with Schnitzler Syndrome, it is important to consult with a healthcare provider for a thorough evaluation. Understanding your symptoms and seeking appropriate treatment can help manage the condition effectively. Remember, while Schnitzler Syndrome is rare, effective treatments are available that can greatly improve your quality of life.

1. Jain T, Offord CP, Kyle RA, Dingli D. Schnitzler syndrome: an under-diagnosed clinical entity. Haematologica. 2013;98(10):1581-1585.
2. De Koning HD. Schnitzler’s syndrome: lessons from 281 cases. Clin Transl Allergy. 2014;4:41.
3. Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis. 2010;5:38.
4. Simon A, Asli B, Braun-Falco M, et al. Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68(5):562-568.
5. Gouveia AI, Micaelo M, Pierdomenico F, Freitas JP. Schnitzler Syndrome: A Dramatic Response to Anakinra. Dermatol Ther (Heidelb). 2016;6(2):299-302.
6. Kurian A, Lee JK, Vadas P. Schnitzler syndrome with cold-induced urticaria. J Dermatol Case Rep. 2010;4(4):50-53.
7. Sokumbi O, Drage LA, Peters MS. Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (1972-2011). J Am Acad Dermatol. 2012;67(6):1289-1295.